Glioblastoma and Monocyte Cell Culture

U87-MG (ATCC HTB-14), U251 (Sigma-Aldrich, Milwaukee, WI, USA), and LN229 (ATCC CRL2611) human glioblastoma cells and THP1 human monocytes (ATCC TIB-202) were passaged fewer than six months and verified by providing companies using short tandem repeat (STR) profiling and confirmed to be Mycoplasma free. Cells for culture were obtained from U87-Bev^R, U87-Bev^S, SF7300, and SF7796 xenografts generated as described.^{14 (link), 15 (link)} Glioblastoma cells were cultured in DMEM High Glucose/F-12 50/50% mixture media with 10% FBS and 1% penicillin/streptomycin at 37 °C. THP1 cells were cultured in RPMI-1640 medium with 10% FBS, L-glutamine (2 mmol/l), 2-mercaptoethanol (55 μM; Gibco) and 1% penicillin/streptomycin at 37 °C.

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Castro B.A., Flanigan P., Jahangiri A., Hoffman D., Chen W., Kuang R., De Lay M., Yagnik G., Wagner J.R., Mascharak S., Sidorov M., Shrivastav S., Kohanbash G., Okada H, & Aghi M.K. (2017). Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy. Oncogene, 36(26), 3749-3759.

Publication 2017

U87-MG LN229 RPMI-1640 L-glutamine 2-mercaptoethanol

2 mercaptoethanol Cells Cells culture Cultured medium Glioblastoma Glucose Human L glutamine Monocytes Mycoplasma Penicillin Short tandem repeat Streptomycin Xenografts

Corresponding Organization :

Other organizations : Neurological Surgery, University of California, San Francisco

Top 5 similar protocols

Variable analysis

independent variables

U87-MG (ATCC HTB-14) human glioblastoma cells
U251 (Sigma-Aldrich, Milwaukee, WI, USA) human glioblastoma cells
LN229 (ATCC CRL2611) human glioblastoma cells
THP1 human monocytes (ATCC TIB-202)
U87-Bev^R^ xenografts
U87-Bev^S^ xenografts
SF7300 xenografts
SF7796 xenografts

dependent variables

Measured outcomes (not explicitly mentioned)

control variables

Cells passaged fewer than six months
Cells verified by providing companies using short tandem repeat (STR) profiling
Cells confirmed to be Mycoplasma free
Glioblastoma cells cultured in DMEM High Glucose/F-12 50/50% mixture media with 10% FBS and 1% penicillin/streptomycin at 37 °C
THP1 cells cultured in RPMI-1640 medium with 10% FBS, L-glutamine (2 mmol/l), 2-mercaptoethanol (55 μM; Gibco) and 1% penicillin/streptomycin at 37 °C

controls

Positive control: None mentioned
Negative control: None mentioned

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!